156 related articles for article (PubMed ID: 30098000)
1. Mechanistic insights of epithelial protein lost in neoplasm in prostate cancer metastasis.
Collins RJ; Morgan LD; Owen S; Ruge F; Jiang WG; Sanders AJ
Int J Cancer; 2018 Nov; 143(10):2537-2550. PubMed ID: 30098000
[TBL] [Abstract][Full Text] [Related]
2. EPLIN: a fundamental actin regulator in cancer metastasis?
Collins RJ; Jiang WG; Hargest R; Mason MD; Sanders AJ
Cancer Metastasis Rev; 2015 Dec; 34(4):753-64. PubMed ID: 26350886
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK.
Lee LF; Louie MC; Desai SJ; Yang J; Chen HW; Evans CP; Kung HJ
Oncogene; 2004 Mar; 23(12):2197-205. PubMed ID: 14767470
[TBL] [Abstract][Full Text] [Related]
4. EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis.
Zhang S; Wang X; Osunkoya AO; Iqbal S; Wang Y; Chen Z; Müller S; Chen Z; Josson S; Coleman IM; Nelson PS; Wang YA; Wang R; Shin DM; Marshall FF; Kucuk O; Chung LW; Zhau HE; Wu D
Oncogene; 2011 Dec; 30(50):4941-52. PubMed ID: 21625216
[TBL] [Abstract][Full Text] [Related]
5. Epithelial protein lost in neoplasm-α (EPLIN-α) is a potential prognostic marker for the progression of epithelial ovarian cancer.
Liu R; Martin TA; Jordan NJ; Ruge F; Ye L; Jiang WG
Int J Oncol; 2016 Jun; 48(6):2488-96. PubMed ID: 27035883
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor promotes protein degradation of epithelial protein lost in neoplasm (EPLIN), a putative metastasis suppressor, during epithelial-mesenchymal transition.
Zhang S; Wang X; Iqbal S; Wang Y; Osunkoya AO; Chen Z; Chen Z; Shin DM; Yuan H; Wang YA; Zhau HE; Chung LW; Ritenour C; Kucuk O; Wu D
J Biol Chem; 2013 Jan; 288(3):1469-79. PubMed ID: 23188829
[TBL] [Abstract][Full Text] [Related]
7. Loss of P53 facilitates invasion and metastasis of prostate cancer cells.
Wang Y; Zhang YX; Kong CZ; Zhang Z; Zhu YY
Mol Cell Biochem; 2013 Dec; 384(1-2):121-7. PubMed ID: 23982184
[TBL] [Abstract][Full Text] [Related]
8. Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells.
Chatterji T; Varkaris AS; Parikh NU; Song JH; Cheng CJ; Schweppe RE; Alexander S; Davis JW; Troncoso P; Friedl P; Kuang J; Lin SH; Gallick GE
Oncotarget; 2015 Apr; 6(12):10175-94. PubMed ID: 25868388
[TBL] [Abstract][Full Text] [Related]
9. [FAK/c-Src signaling pathway mediates the expression of cell surface HSP90 in cultured human prostate cancer cells and its association with their invasive capability].
Liu XG; Guo Y; Yan ZQ; Guo MY; Zhang ZG; Guo CA
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):340-4. PubMed ID: 21875461
[TBL] [Abstract][Full Text] [Related]
10. PI3Kp110-, Src-, FAK-dependent and DOCK2-independent migration and invasion of CXCL13-stimulated prostate cancer cells.
El Haibi CP; Sharma PK; Singh R; Johnson PR; Suttles J; Singh S; Lillard JW
Mol Cancer; 2010 Apr; 9():85. PubMed ID: 20412587
[TBL] [Abstract][Full Text] [Related]
11. BKCa promotes growth and metastasis of prostate cancer through facilitating the coupling between αvβ3 integrin and FAK.
Du C; Zheng Z; Li D; Chen L; Li N; Yi X; Yang Y; Guo F; Liu W; Xie X; Xie M
Oncotarget; 2016 Jun; 7(26):40174-40188. PubMed ID: 27233075
[TBL] [Abstract][Full Text] [Related]
12. c-Src, Insulin-Like Growth Factor I Receptor, G-Protein-Coupled Receptor Kinases and Focal Adhesion Kinase are Enriched Into Prostate Cancer Cell Exosomes.
DeRita RM; Zerlanko B; Singh A; Lu H; Iozzo RV; Benovic JL; Languino LR
J Cell Biochem; 2017 Jan; 118(1):66-73. PubMed ID: 27232975
[TBL] [Abstract][Full Text] [Related]
13. Bit1 knockdown contributes to growth suppression as well as the decreases of migration and invasion abilities in esophageal squamous cell carcinoma via suppressing FAK-paxillin pathway.
Fan T; Chen J; Zhang L; Gao P; Hui Y; Xu P; Zhang X; Liu H
Mol Cancer; 2016 Mar; 15():23. PubMed ID: 26956728
[TBL] [Abstract][Full Text] [Related]
14. Alterations in the focal adhesion kinase/Src signal transduction pathway correlate with increased migratory capacity of prostate carcinoma cells.
Slack JK; Adams RB; Rovin JD; Bissonette EA; Stoker CE; Parsons JT
Oncogene; 2001 Mar; 20(10):1152-63. PubMed ID: 11313859
[TBL] [Abstract][Full Text] [Related]
15. Reorganization of the integrin alpha2 subunit controls cell adhesion and cancer cell invasion in prostate cancer.
Van Slambrouck S; Jenkins AR; Romero AE; Steelant WF
Int J Oncol; 2009 Jun; 34(6):1717-26. PubMed ID: 19424590
[TBL] [Abstract][Full Text] [Related]
16. Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines.
Chikara S; Lindsey K; Borowicz P; Christofidou-Solomidou M; Reindl KM
BMC Complement Altern Med; 2017 Jan; 17(1):30. PubMed ID: 28068967
[TBL] [Abstract][Full Text] [Related]
17. EPLIN-α expression in human oesophageal cancer and its impact on cellular aggressiveness and clinical outcome.
Liu Y; Sanders AJ; Zhang L; Jiang WG
Anticancer Res; 2012 Apr; 32(4):1283-9. PubMed ID: 22493360
[TBL] [Abstract][Full Text] [Related]
18. Eplin-alpha expression in human breast cancer, the impact on cellular migration and clinical outcome.
Jiang WG; Martin TA; Lewis-Russell JM; Douglas-Jones A; Ye L; Mansel RE
Mol Cancer; 2008 Sep; 7():71. PubMed ID: 18796137
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulation.
Wei J; Xu G; Wu M; Zhang Y; Li Q; Liu P; Zhu T; Song A; Zhao L; Han Z; Chen G; Wang S; Meng L; Zhou J; Lu Y; Wang S; Ma D
Anticancer Res; 2008; 28(1A):327-34. PubMed ID: 18383865
[TBL] [Abstract][Full Text] [Related]
20. BTG2 suppresses cancer cell migration through inhibition of Src-FAK signaling by downregulation of reactive oxygen species generation in mitochondria.
Lim SK; Choi YW; Lim IK; Park TJ
Clin Exp Metastasis; 2012 Dec; 29(8):901-13. PubMed ID: 22562501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
